Get started Log in

ZLD — Zelira Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Brief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
16/01/2026 06:22
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
15/01/2026 23:44
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
16/07/2024 03:15
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
04/07/2024 02:11
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility
01/07/2024 02:41
Brief: Zelira Therapeutics Says HY Net Loss Attributable A$34.1 Million Versus Loss A$3.3 Million
22/02/2024 06:42
Brief: Zelira Therapeutics Closes A$3.25 Mln Funding As Part Of Hope Spv Fundraise
17/08/2023 02:18
Brief: Zelira Therapeutics Seeks Trading Halt
29/05/2023 24:07
Australia's Zelira climbs on funding for HOPE 1's FDA trials
22/05/2023 06:17
Brief: Zelira Therapeutics Says Additional $3.25 Million Of Funding Into Hope® Special Purpose Vehicle
22/05/2023 02:25
Brief: Zelira Therapeutics Raises A$1.77 Mln From U.S.-Based Investors
15/03/2023 01:16
Brief: Zelira Therapeutics Seeks Trading Halt
12/03/2023 22:17
Brief: Zelira Therapeutics Posts HY Net Loss Of A$3.7 Million
28/02/2023 03:53
Brief: Zelira Therapeutics Seeks Trading Halt
16/02/2023 22:33
Brief: Zelira Therapeutics Secures Us$8.6 Million Cornerstone Funding
15/02/2023 01:12
Brief: Zelira Therapeutics Seeks Trading Halt
12/02/2023 22:26
Brief: Zelira Therapeutics Launches Zyraydi B2b Technology To Create Pharma-Grade Cannabis Capsules & Tablets For Global Markets
20/09/2022 14:35
Brief: Zelira Therapeutics Says FY Net Loss Attributable A$12.4 Million
31/08/2022 07:36
Brief: Zelira Therapeutics Says Zenivol Receives Formal Approval From German Regulatory
13/07/2022 02:24
Australia's Zelira Therapeutics rises on Gerrman regulatory nod for insomnia medication
13/07/2022 02:10